275 related articles for article (PubMed ID: 28678648)
1. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
3. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
4. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of voltage-gated potassium ion channel molecule Kv1.3 in mechanisms of colorectal cancer.
He T; Wang C; Zhang M; Zhang X; Zheng S; Linghu E; Guo M
Discov Med; 2017 Mar; 23(126):155-162. PubMed ID: 28472608
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.
Wang Y; Zhang Y; Herman JG; Linghu E; Guo M
Oncotarget; 2017 Sep; 8(41):70035-70048. PubMed ID: 29050260
[TBL] [Abstract][Full Text] [Related]
8. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
[TBL] [Abstract][Full Text] [Related]
9. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.
Hu S; Cao B; Zhang M; Linghu E; Zhan Q; Brock MV; Herman JG; Mao G; Guo M
Am J Cancer Res; 2015; 5(2):651-62. PubMed ID: 25973304
[TBL] [Abstract][Full Text] [Related]
11. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.
Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
[TBL] [Abstract][Full Text] [Related]
12. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
13. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
Piazzi G; Selgrad M; Garcia M; Ceccarelli C; Fini L; Bianchi P; Laghi L; D'Angelo L; Paterini P; Malfertheiner P; Chieco P; Boland CR; Bazzoli F; Ricciardiello L
Br J Cancer; 2013 Apr; 108(8):1750-6. PubMed ID: 23579212
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
15. Methylation of
Li H; Yang W; Zhang M; He T; Zhou F; G Herman J; Hu L; Guo M
Epigenomics; 2021 Sep; 13(17):1403-1419. PubMed ID: 34558311
[TBL] [Abstract][Full Text] [Related]
16. Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer.
He T; Zhang M; Zheng R; Zheng S; Linghu E; Herman JG; Guo M
Epigenomics; 2017 Jun; 9(6):849-862. PubMed ID: 28403629
[TBL] [Abstract][Full Text] [Related]
17. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
18. GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer.
Pelosof L; Yerram S; Armstrong T; Chu N; Danilova L; Yanagisawa B; Hidalgo M; Azad N; Herman JG
Epigenetics; 2017 Jul; 12(7):540-550. PubMed ID: 27918237
[TBL] [Abstract][Full Text] [Related]
19. Altered ARID1A expression in colorectal cancer.
Erfani M; Hosseini SV; Mokhtari M; Zamani M; Tahmasebi K; Alizadeh Naini M; Taghavi A; Carethers JM; Koi M; Brim H; Mokarram P; Ashktorab H
BMC Cancer; 2020 Apr; 20(1):350. PubMed ID: 32334542
[TBL] [Abstract][Full Text] [Related]
20. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
